Bryan J. McMichael

CIK: 0001944868

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CHRS

Coherus Oncology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

CHRS
Coherus Oncology, Inc.
May 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
25K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
25K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
15K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
25K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
100K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
25K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
15K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
25K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
25K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
30K shares-
CHRS
Coherus Oncology, Inc.
May 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
CHRS
Coherus Oncology, Inc.
Jan 22, 2026
Award(A)
Direct
112.5K shares-
CHRS
Coherus Oncology, Inc.
Jan 20, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $1.55$3K
CHRS
Coherus BioSciences, Inc.
May 7, 2025
Award(A)
Stock Option (Right to Buy)
Direct
200K shares-
CHRS
Coherus BioSciences, Inc.
Jan 20, 2025
Tax Payment(F)
Direct
1.7K shares at avg. $1.39$2K
CHRS
Coherus BioSciences, Inc.
Jan 7, 2025
Tax Payment(F)
Direct
1.7K shares at avg. $1.57$3K
CHRS
Coherus BioSciences, Inc.
Jan 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
160K shares-

		Type	Shares	Price		Ownership
May 29, 2026	CHRS Coherus Oncology, Inc.	Award(A) Stock Option (Right to Buy)	25,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Award(A) Stock Option (Right to Buy)	25,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Award(A) Stock Option (Right to Buy)	15,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Award(A) Stock Option (Right to Buy)	25,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Disposition(D) Stock Option (Right to Buy)	100,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Disposition(D) Stock Option (Right to Buy)	25,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Disposition(D) Stock Option (Right to Buy)	15,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Disposition(D) Stock Option (Right to Buy)	25,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Disposition(D) Stock Option (Right to Buy)	25,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Disposition(D) Stock Option (Right to Buy)	30,000	-	-	Direct
May 29, 2026	CHRS Coherus Oncology, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Jan 22, 2026	CHRS Coherus Oncology, Inc.	Award(A)	112,500	-	$0	Direct
Jan 20, 2026	CHRS Coherus Oncology, Inc.	Tax Payment(F)	1,715	$1.55	$2,658	Direct
May 7, 2025	CHRS Coherus BioSciences, Inc.	Award(A) Stock Option (Right to Buy)	200,000	-	-	Direct
Jan 20, 2025	CHRS Coherus BioSciences, Inc.	Tax Payment(F)	1,711	$1.39	$2,378	Direct
Jan 7, 2025	CHRS Coherus BioSciences, Inc.	Tax Payment(F)	1,711	$1.57	$2,686	Direct
Jan 3, 2025	CHRS Coherus BioSciences, Inc.	Award(A) Stock Option (Right to Buy)	160,000	-	-	Direct

1-18 of 18 transactions

About McMichael Bryan J

McMichael Bryan J (SEC CIK 0001944868) files insider reports with the SEC as Chief Financial Officer of Coherus Oncology, Inc. (CHRS).

Signal8 holds 7 ownership filings by McMichael Bryan J, all Form 4s, filed between Jan 7, 2025 and Jun 2, 2026. Those filings report 18 transactions, from Jan 3, 2025 to May 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McMichael Bryan J's filings is in REDWOOD CITY, CA.

Recent filings by McMichael Bryan J

May 29, 2026: Grants or awards of CHRS derivative securities (5 lines, Form 4, code A).
May 29, 2026: Disposition to issuer transactions of CHRS derivative securities (6 lines, Form 4, code D).
May 29, 2026: Grant or award of CHRS derivative securities (Form 4, code A).
Jan 22, 2026: Grant or award of CHRS shares (Form 4, code A).
Jan 20, 2026: Tax withholding of CHRS shares (Form 4, code F).

Other insiders filing for Coherus Oncology, Inc. (CHRS)

How to read Form 4 transaction codes